ID   BCAT2_HUMAN             Reviewed;         392 AA.
AC   O15382; B2RB87; O00269; Q96KG1; Q9BTB6; Q9BUU6;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   02-MAY-2002, sequence version 2.
DT   10-MAY-2017, entry version 168.
DE   RecName: Full=Branched-chain-amino-acid aminotransferase, mitochondrial;
DE            Short=BCAT(m);
DE            EC=2.6.1.42;
DE   AltName: Full=Placental protein 18;
DE            Short=PP18;
DE   Flags: Precursor;
GN   Name=BCAT2; Synonyms=BCATM, BCT2, ECA40;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A), AND VARIANT ARG-186.
RX   PubMed=9165094; DOI=10.1016/S0167-4838(97)00044-7;
RA   Bledsoe R.K., Dawson P.A., Hutson S.M.;
RT   "Cloning of the rat and human mitochondrial branched chain
RT   aminotransferases (BCATm).";
RL   Biochim. Biophys. Acta 1339:9-13(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A AND B).
RC   TISSUE=Placenta;
RX   PubMed=11170829; DOI=10.1053/plac.2000.0603;
RA   Than N.G., Sumegi B., Than G.N., Bellyei S., Bohn H.;
RT   "Molecular cloning and characterization of placental tissue protein 18
RT   (PP18a)/human mitochondrial branched-chain aminotransferase (BCATm)
RT   and its novel alternatively spliced PP18b variant.";
RL   Placenta 22:235-243(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM A).
RC   TISSUE=Heart;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM A).
RC   TISSUE=Lung, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 27-392 (ISOFORM A), AND VARIANT ARG-186.
RC   TISSUE=Brain;
RX   PubMed=8702755; DOI=10.1074/jbc.271.34.20242;
RA   Eden A., Simchen G., Benvenisty N.;
RT   "Two yeast homologs of ECA39, a target for c-Myc regulation, code for
RT   cytosolic and mitochondrial branched-chain amino acid
RT   aminotransferases.";
RL   J. Biol. Chem. 271:20242-20245(1996).
RN   [7]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-321, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 28-392 IN COMPLEX WITH
RP   COFACTOR, AND SUBUNIT.
RX   PubMed=11264579; DOI=10.1107/S0907444901001925;
RA   Yennawar N.H., Dunbar J., Conway M.E., Hutson S.M., Farber G.K.;
RT   "The structure of human mitochondrial branched-chain
RT   aminotransferase.";
RL   Acta Crystallogr. D 57:506-515(2001).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 28-392 IN COMPLEXES WITH
RP   COFACTOR AND SUBSTRATES.
RX   PubMed=12269802; DOI=10.1021/bi020221c;
RA   Yennawar N.H., Conway M.E., Yennawar H.P., Farber G.K., Hutson S.M.;
RT   "Crystal structures of human mitochondrial branched chain
RT   aminotransferase reaction intermediates: ketimine and pyridoxamine
RT   phosphate forms.";
RL   Biochemistry 41:11592-11601(2002).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF OF 28-392 IN COMPLEXES WITH
RP   COFACTOR AND SUBSTRATE ANALOGS.
RX   PubMed=16141215; DOI=10.1074/jbc.M506486200;
RA   Goto M., Miyahara I., Hirotsu K., Conway M., Yennawar N., Islam M.M.,
RA   Hutson S.M.;
RT   "Structural determinants for branched-chain aminotransferase isozyme-
RT   specific inhibition by the anticonvulsant drug gabapentin.";
RL   J. Biol. Chem. 280:37246-37256(2005).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 28-392 IN COMPLEXES WITH
RP   COFACTOR AND SUBSTRATE ANALOGS, AND MUTAGENESIS OF CYS-342 AND
RP   CYS-345.
RX   PubMed=17050531; DOI=10.1074/jbc.M607552200;
RA   Yennawar N.H., Islam M.M., Conway M., Wallin R., Hutson S.M.;
RT   "Human mitochondrial branched chain aminotransferase isozyme:
RT   structural role of the CXXC center in catalysis.";
RL   J. Biol. Chem. 281:39660-39671(2006).
CC   -!- FUNCTION: Catalyzes the first reaction in the catabolism of the
CC       essential branched chain amino acids leucine, isoleucine, and
CC       valine. May also function as a transporter of branched chain
CC       alpha-keto acids.
CC   -!- CATALYTIC ACTIVITY: L-leucine + 2-oxoglutarate = 4-methyl-2-
CC       oxopentanoate + L-glutamate.
CC   -!- CATALYTIC ACTIVITY: L-isoleucine + 2-oxoglutarate = (S)-3-methyl-
CC       2-oxopentanoate + L-glutamate.
CC   -!- CATALYTIC ACTIVITY: L-valine + 2-oxoglutarate = 3-methyl-2-
CC       oxobutanoate + L-glutamate.
CC   -!- COFACTOR:
CC       Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:11264579}.
CC   -!- SUBCELLULAR LOCATION: Isoform A: Mitochondrion.
CC   -!- SUBCELLULAR LOCATION: Isoform B: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=A;
CC         IsoId=O15382-1; Sequence=Displayed;
CC       Name=B;
CC         IsoId=O15382-2; Sequence=VSP_000236;
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- SIMILARITY: Belongs to the class-IV pyridoxal-phosphate-dependent
CC       aminotransferase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB53087.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U68418; AAB67672.1; -; mRNA.
DR   EMBL; AF268047; AAK38368.1; -; mRNA.
DR   EMBL; AF268048; AAK38369.1; -; mRNA.
DR   EMBL; AK314548; BAG37134.1; -; mRNA.
DR   EMBL; CH471177; EAW52403.1; -; Genomic_DNA.
DR   EMBL; BC001900; AAH01900.1; -; mRNA.
DR   EMBL; BC004243; AAH04243.2; -; mRNA.
DR   EMBL; U62739; AAB53087.1; ALT_INIT; mRNA.
DR   CCDS; CCDS12735.1; -. [O15382-1]
DR   CCDS; CCDS54290.1; -. [O15382-2]
DR   RefSeq; NP_001158245.1; NM_001164773.1. [O15382-2]
DR   RefSeq; NP_001181.2; NM_001190.3. [O15382-1]
DR   RefSeq; NP_001271254.1; NM_001284325.1.
DR   UniGene; Hs.512670; -.
DR   PDB; 1EKF; X-ray; 1.95 A; A/B=28-392.
DR   PDB; 1EKP; X-ray; 2.50 A; A/B=28-392.
DR   PDB; 1EKV; X-ray; 2.25 A; A/B=28-392.
DR   PDB; 1KT8; X-ray; 1.90 A; A/B=28-392.
DR   PDB; 1KTA; X-ray; 1.90 A; A/B=28-392.
DR   PDB; 2A1H; X-ray; 1.80 A; A/B=28-392.
DR   PDB; 2HDK; X-ray; 2.40 A; A/B=28-392.
DR   PDB; 2HG8; X-ray; 1.80 A; A/B=28-392.
DR   PDB; 2HGW; X-ray; 1.98 A; A/B=28-392.
DR   PDB; 2HGX; X-ray; 1.80 A; A/B=28-392.
DR   PDB; 2HHF; X-ray; 1.80 A; A/B=28-392.
DR   PDB; 5BWR; X-ray; 2.20 A; A/B=28-392.
DR   PDB; 5BWT; X-ray; 2.20 A; A/B=28-392.
DR   PDB; 5BWU; X-ray; 2.17 A; A/B=28-392.
DR   PDB; 5BWV; X-ray; 1.86 A; A/B=28-392.
DR   PDB; 5BWW; X-ray; 1.82 A; A/B=28-392.
DR   PDB; 5BWX; X-ray; 1.70 A; A/B=28-392.
DR   PDB; 5CR5; X-ray; 1.61 A; A/B=28-392.
DR   PDB; 5HNE; X-ray; 2.04 A; A/B=28-392.
DR   PDB; 5I5S; X-ray; 2.06 A; A/B=28-392.
DR   PDB; 5I5T; X-ray; 2.31 A; A/B=28-392.
DR   PDB; 5I5U; X-ray; 2.40 A; A/B=28-392.
DR   PDB; 5I5V; X-ray; 1.94 A; A/B=28-392.
DR   PDB; 5I5W; X-ray; 2.40 A; A/B=28-392.
DR   PDB; 5I5X; X-ray; 1.65 A; A/B=28-392.
DR   PDB; 5I5Y; X-ray; 1.81 A; A/B=28-392.
DR   PDB; 5I60; X-ray; 2.12 A; A/B=28-392.
DR   PDBsum; 1EKF; -.
DR   PDBsum; 1EKP; -.
DR   PDBsum; 1EKV; -.
DR   PDBsum; 1KT8; -.
DR   PDBsum; 1KTA; -.
DR   PDBsum; 2A1H; -.
DR   PDBsum; 2HDK; -.
DR   PDBsum; 2HG8; -.
DR   PDBsum; 2HGW; -.
DR   PDBsum; 2HGX; -.
DR   PDBsum; 2HHF; -.
DR   PDBsum; 5BWR; -.
DR   PDBsum; 5BWT; -.
DR   PDBsum; 5BWU; -.
DR   PDBsum; 5BWV; -.
DR   PDBsum; 5BWW; -.
DR   PDBsum; 5BWX; -.
DR   PDBsum; 5CR5; -.
DR   PDBsum; 5HNE; -.
DR   PDBsum; 5I5S; -.
DR   PDBsum; 5I5T; -.
DR   PDBsum; 5I5U; -.
DR   PDBsum; 5I5V; -.
DR   PDBsum; 5I5W; -.
DR   PDBsum; 5I5X; -.
DR   PDBsum; 5I5Y; -.
DR   PDBsum; 5I60; -.
DR   ProteinModelPortal; O15382; -.
DR   SMR; O15382; -.
DR   BioGrid; 107062; 14.
DR   IntAct; O15382; 3.
DR   STRING; 9606.ENSP00000322991; -.
DR   BindingDB; O15382; -.
DR   ChEMBL; CHEMBL3616354; -.
DR   DrugBank; DB04074; Alpha-ketoisovalerate.
DR   DrugBank; DB00142; L-Glutamic Acid.
DR   DrugBank; DB00167; L-Isoleucine.
DR   DrugBank; DB00149; L-Leucine.
DR   DrugBank; DB02635; N-[O-Phosphono-Pyridoxyl]-Isoleucine.
DR   DrugBank; DB00114; Pyridoxal Phosphate.
DR   DrugBank; DB02142; Pyridoxamine-5'-Phosphate.
DR   GuidetoPHARMACOLOGY; 2893; -.
DR   iPTMnet; O15382; -.
DR   PhosphoSitePlus; O15382; -.
DR   BioMuta; BCAT2; -.
DR   EPD; O15382; -.
DR   MaxQB; O15382; -.
DR   PaxDb; O15382; -.
DR   PeptideAtlas; O15382; -.
DR   PRIDE; O15382; -.
DR   DNASU; 587; -.
DR   Ensembl; ENST00000316273; ENSP00000322991; ENSG00000105552. [O15382-1]
DR   Ensembl; ENST00000545387; ENSP00000440973; ENSG00000105552. [O15382-2]
DR   GeneID; 587; -.
DR   KEGG; hsa:587; -.
DR   UCSC; uc002pkr.4; human. [O15382-1]
DR   CTD; 587; -.
DR   DisGeNET; 587; -.
DR   GeneCards; BCAT2; -.
DR   HGNC; HGNC:977; BCAT2.
DR   HPA; HPA054091; -.
DR   MalaCards; BCAT2; -.
DR   MIM; 113530; gene.
DR   neXtProt; NX_O15382; -.
DR   OpenTargets; ENSG00000105552; -.
DR   PharmGKB; PA25289; -.
DR   eggNOG; KOG0975; Eukaryota.
DR   eggNOG; COG0115; LUCA.
DR   GeneTree; ENSGT00390000009532; -.
DR   HOGENOM; HOG000276704; -.
DR   HOVERGEN; HBG050678; -.
DR   InParanoid; O15382; -.
DR   KO; K00826; -.
DR   PhylomeDB; O15382; -.
DR   TreeFam; TF300882; -.
DR   BRENDA; 2.6.1.42; 2681.
DR   Reactome; R-HSA-70895; Branched-chain amino acid catabolism.
DR   SABIO-RK; O15382; -.
DR   ChiTaRS; BCAT2; human.
DR   EvolutionaryTrace; O15382; -.
DR   GenomeRNAi; 587; -.
DR   PRO; PR:O15382; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000105552; -.
DR   CleanEx; HS_BCAT2; -.
DR   ExpressionAtlas; O15382; baseline and differential.
DR   Genevisible; O15382; HS.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; TAS:ProtInc.
DR   GO; GO:0004084; F:branched-chain-amino-acid transaminase activity; EXP:Reactome.
DR   GO; GO:0052656; F:L-isoleucine transaminase activity; IEA:UniProtKB-EC.
DR   GO; GO:0052654; F:L-leucine transaminase activity; IEA:UniProtKB-EC.
DR   GO; GO:0052655; F:L-valine transaminase activity; IEA:UniProtKB-EC.
DR   GO; GO:0009082; P:branched-chain amino acid biosynthetic process; TAS:ProtInc.
DR   GO; GO:0009083; P:branched-chain amino acid catabolic process; TAS:Reactome.
DR   GO; GO:0006550; P:isoleucine catabolic process; IEA:Ensembl.
DR   GO; GO:0009098; P:leucine biosynthetic process; IBA:GO_Central.
DR   GO; GO:0010817; P:regulation of hormone levels; IEA:Ensembl.
DR   GO; GO:0009099; P:valine biosynthetic process; IBA:GO_Central.
DR   CDD; cd01557; BCAT_beta_family; 1.
DR   InterPro; IPR001544; Aminotrans_IV.
DR   InterPro; IPR018300; Aminotrans_IV_CS.
DR   InterPro; IPR005786; B_amino_transII.
DR   InterPro; IPR033939; BCAT_family.
DR   Pfam; PF01063; Aminotran_4; 1.
DR   PIRSF; PIRSF006468; BCAT1; 1.
DR   SUPFAM; SSF56752; SSF56752; 1.
DR   TIGRFAMs; TIGR01123; ilvE_II; 1.
DR   PROSITE; PS00770; AA_TRANSFER_CLASS_4; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing;
KW   Amino-acid biosynthesis; Aminotransferase;
KW   Branched-chain amino acid biosynthesis; Complete proteome; Cytoplasm;
KW   Mitochondrion; Polymorphism; Pyridoxal phosphate; Reference proteome;
KW   Transferase; Transit peptide.
FT   TRANSIT       1     27       Mitochondrion.
FT   CHAIN        28    392       Branched-chain-amino-acid
FT                                aminotransferase, mitochondrial.
FT                                /FTId=PRO_0000001271.
FT   BINDING     168    168       Substrate.
FT   MOD_RES     229    229       N6-(pyridoxal phosphate)lysine.
FT   MOD_RES     321    321       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VAR_SEQ       9    100       Missing (in isoform B).
FT                                {ECO:0000303|PubMed:11170829}.
FT                                /FTId=VSP_000236.
FT   VARIANT     186    186       T -> R (in dbSNP:rs11548193).
FT                                {ECO:0000269|PubMed:8702755,
FT                                ECO:0000269|PubMed:9165094}.
FT                                /FTId=VAR_048234.
FT   MUTAGEN     342    342       C->A: Reduces activity about 6-fold.
FT                                {ECO:0000269|PubMed:17050531}.
FT   MUTAGEN     345    345       C->A: Slight reduction of activity.
FT                                {ECO:0000269|PubMed:17050531}.
FT   CONFLICT    154    154       V -> L (in Ref. 6; AAB53087).
FT                                {ECO:0000305}.
FT   CONFLICT    207    207       T -> N (in Ref. 6; AAB53087).
FT                                {ECO:0000305}.
FT   CONFLICT    214    216       DPA -> EPT (in Ref. 6; AAB53087).
FT                                {ECO:0000305}.
FT   CONFLICT    253    253       L -> F (in Ref. 6; AAB53087).
FT                                {ECO:0000305}.
FT   CONFLICT    326    326       A -> P (in Ref. 6; AAB53087).
FT                                {ECO:0000305}.
FT   CONFLICT    330    330       G -> A (in Ref. 6; AAB53087).
FT                                {ECO:0000305}.
FT   CONFLICT    349    349       R -> G (in Ref. 6; AAB53087).
FT                                {ECO:0000305}.
FT   CONFLICT    357    357       L -> F (in Ref. 6; AAB53087).
FT                                {ECO:0000305}.
FT   CONFLICT    370    370       L -> F (in Ref. 6; AAB53087).
FT                                {ECO:0000305}.
FT   HELIX        34     36       {ECO:0000244|PDB:5CR5}.
FT   STRAND       51     53       {ECO:0000244|PDB:2HG8}.
FT   TURN         57     59       {ECO:0000244|PDB:5I5X}.
FT   STRAND       63     71       {ECO:0000244|PDB:5CR5}.
FT   STRAND       72     75       {ECO:0000244|PDB:1EKF}.
FT   STRAND       79     82       {ECO:0000244|PDB:5CR5}.
FT   STRAND       86     88       {ECO:0000244|PDB:5CR5}.
FT   HELIX        93     96       {ECO:0000244|PDB:5CR5}.
FT   STRAND      100    102       {ECO:0000244|PDB:5CR5}.
FT   STRAND      105    109       {ECO:0000244|PDB:5CR5}.
FT   STRAND      115    119       {ECO:0000244|PDB:5CR5}.
FT   HELIX       120    133       {ECO:0000244|PDB:5CR5}.
FT   HELIX       141    154       {ECO:0000244|PDB:5CR5}.
FT   HELIX       156    158       {ECO:0000244|PDB:5CR5}.
FT   STRAND      162    164       {ECO:0000244|PDB:1EKP}.
FT   STRAND      166    175       {ECO:0000244|PDB:5CR5}.
FT   STRAND      181    183       {ECO:0000244|PDB:2HG8}.
FT   STRAND      188    197       {ECO:0000244|PDB:5CR5}.
FT   HELIX       202    204       {ECO:0000244|PDB:5BWX}.
FT   STRAND      209    213       {ECO:0000244|PDB:5CR5}.
FT   HELIX       231    233       {ECO:0000244|PDB:5CR5}.
FT   TURN        234    236       {ECO:0000244|PDB:5CR5}.
FT   HELIX       237    246       {ECO:0000244|PDB:5CR5}.
FT   STRAND      250    256       {ECO:0000244|PDB:5CR5}.
FT   TURN        257    260       {ECO:0000244|PDB:5CR5}.
FT   STRAND      261    265       {ECO:0000244|PDB:5CR5}.
FT   STRAND      268    275       {ECO:0000244|PDB:5CR5}.
FT   STRAND      281    285       {ECO:0000244|PDB:5CR5}.
FT   STRAND      289    292       {ECO:0000244|PDB:5CR5}.
FT   HELIX       296    308       {ECO:0000244|PDB:5CR5}.
FT   STRAND      310    315       {ECO:0000244|PDB:5CR5}.
FT   HELIX       320    328       {ECO:0000244|PDB:5CR5}.
FT   STRAND      332    339       {ECO:0000244|PDB:5CR5}.
FT   TURN        340    342       {ECO:0000244|PDB:5CR5}.
FT   STRAND      343    352       {ECO:0000244|PDB:5CR5}.
FT   STRAND      355    358       {ECO:0000244|PDB:5CR5}.
FT   HELIX       361    364       {ECO:0000244|PDB:5CR5}.
FT   HELIX       367    380       {ECO:0000244|PDB:5CR5}.
FT   STRAND      389    391       {ECO:0000244|PDB:5CR5}.
SQ   SEQUENCE   392 AA;  44288 MW;  EC07047264B190DA CRC64;
     MAAAALGQIW ARKLLSVPWL LCGPRRYASS SFKAADLQLE MTQKPHKKPG PGEPLVFGKT
     FTDHMLMVEW NDKGWGQPRI QPFQNLTLHP ASSSLHYSLQ LFEGMKAFKG KDQQVRLFRP
     WLNMDRMLRS AMRLCLPSFD KLELLECIRR LIEVDKDWVP DAAGTSLYVR PVLIGNEPSL
     GVSQPTRALL FVILCPVGAY FPGGSVTPVS LLADPAFIRA WVGGVGNYKL GGNYGPTVLV
     QQEALKRGCE QVLWLYGPDH QLTEVGTMNI FVYWTHEDGV LELVTPPLNG VILPGVVRQS
     LLDMAQTWGE FRVVERTITM KQLLRALEEG RVREVFGSGT ACQVCPVHRI LYKDRNLHIP
     TMENGPELIL RFQKELKEIQ YGIRAHEWMF PV
//
